Ahmedabad crash: At least 20 on-ground deaths confirmed; 247 DNA matches complete, 232 bodies handed over
By 6 pm on Saturday, the process of matching a total of 247 DNA samples of the victims with their living family members had been completed, said officials at the Ahmedabad Civil Hospital. These included 238 people who were on board the ill-fated Boeing aircraft, the officials added.
As many as 241 out of the 242 passengers who boarded the plane lost their lives in the tragedy.
Meanwhile, the process of DNA analysis of samples taken from the bodies of victims with those of their living relatives is still underway, almost 10 days after the crash.
Of the 247 DNA matches, 232 bodies have been handed over to the families. Out of the remaining 15 identified bodies, three families are awaiting the remains of their other family members since more than one of their kin perished in the crash. Six bodies are ready to be handed over while scheduling with families is underway to hand over the mortal remains of another six passengers.
The Indian Express has learnt that of the 247 bodies identified through DNA as of Saturday evening, 175 were Indian, 52 British, seven Portuguese, one Canadian, and 12 non-passengers.
Dr Rakesh Joshi, Medical Superintendent of Ahmedabad Civil Hospital, confirmed that of the 12 non-passengers whose bodies had been handed over to families, nine had died on the spot and their identification had to be carried out through DNA analysis. Three of the victims were admitted to the hospital in a critical state and succumbed to their injuries later.
On bodies that could be identified without the need for DNA profiling, Dr Joshi said, 'We had handed over eight such bodies to their families. In these cases, the need for DNA profiling did not arise because their bodies were identifiable.'
All these eight persons were those who had died on the ground, bringing the total number of casualties in the Atulyam hostels of B J Medical College and those on the road to 20.
This also takes the estimated death toll to 261 persons, including 241 airline passengers.
Resampling needed in some cases
Meanwhile, The Indian Express has learnt that some families had to give additional DNA samples. This is because initial blood samples were taken from distant relatives, which may have not been enough to prove a blood relation, people in the know of the matter said. There could be other problems with the blood samples during the DNA profiling process, they added.
Dr Joshi said, 'We have done resampling for some families. In cases where a delay was taking place, we asked for additional samples from families. The most effective blood samples to match are between a parent and a child. But in the earlier phase of the tragedy, immediate family may not have been available. Since they came later, we took additional samples from them. In some cases, we were about to take additional samples but before that, we received the news that the body had been identified.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Govt Reaffirms COVID Vaccine Safety as Private Hospitals Stay Quiet—Raising Questions
New Delhi: As concerns about sudden cardiac deaths among young adults continue to make headlines, the Indian government and top pharmaceutical voices have reiterated that COVID-19 vaccines are safe, effective, and not linked to heart-related fatalities. However, a curious silence from leading private hospitals and senior doctors—who played a central role in the nationwide vaccination drive—is beginning to raise questions about transparency and public engagement. Private hospitals, which were deeply involved in the vaccination rollout, remaining silent at this juncture cannot be taken lightly. This silence is not necessarily an admission of doubt, but the absence of their voice in the public domain—especially when scientific clarity is most needed—has not gone unnoticed. Health authorities maintain that India's vaccines have undergone rigorous testing and regulatory scrutiny. Dr. G.V.J.A. Harshavardhan, Director General of the Indian Vaccine Manufacturers Association, in an official statement, reaffirmed:'COVID-19 vaccines of India were developed and manufactured with the highest safety and quality standards. Patient safety and product quality are always prioritized during the vaccine development and its manufacture.' He added that all vaccines were approved for Emergency Use Authorization (EUA) based on extensive preclinical and clinical trials demonstrating safety, efficacy, and immunogenicity. 'Prior to their release, all COVID-19 vaccines are tested extensively for safety by the manufacturers and are also provided Batch Release Certification by the Central Drugs Laboratory (CDL), Kasauli, Himachal Pradesh, of the Ministry of Health and Family Welfare,' he said. 'The strengths of innovation and large-scale high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem.' India's Global Vaccine Leadership During the pandemic, India supplied vaccines to over 90 countries under its Vaccine Maitri initiative. Officials cite this as proof of international confidence in Indian-made vaccines. Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, echoed this sentiment and raised concerns about the harmful impact of misinformation. 'The Indian pharmaceutical industry is a knowledge-driven sector and plays a vital role in global health. India accounts for 60 per cent of global vaccine production. These vaccines have been well documented and rigorously tested as per regulatory processes,' he said. 'Misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally.' Private Hospitals, Key Vaccination Partners, Maintain Silence as Questions Mount Despite these strong assurances, prominent private hospitals and top medical experts associated with them have largely refrained from commenting on the rising concerns related to post-vaccination adverse events . ETHealthworld reached out to several hospital networks involved in mass immunization, but most declined to comment or said they had no official position at this time. This silence is puzzling. These institutions were once highly vocal during the vaccine rollout, actively conducting drives, issuing FAQs, and promoting vaccine awareness. Their muted response today, amid public anxiety, is being seen as a missed opportunity to educate and reassure. 'We're not blaming hospitals,' said a senior public health expert, 'but their absence in this conversation is noticeable. If the data supports vaccine safety—as government and pharma leaders insist—then trusted medical institutions should lead from the front, explaining how adverse events are monitored and managed. Silence only deepens doubt.' Experts say the role of private hospitals is critical not just in vaccine delivery, but in reinforcing public trust. With vaccine hesitancy rising globally, communication gaps—especially from frontline players—risk allowing misinformation to fill the void. Why Transparency Now Matters More Than Ever? In an age where misinformation travels faster than facts, silence can be dangerous. Transparency—even when dealing with rare or uncomfortable adverse events—is essential to preserving long-term confidence in scientific interventions. India's COVID-19 vaccination program has been widely praised for its scale and speed. But success in public health doesn't end with delivery—it continues through open dialogue, education, and the courage to confront evolving narratives head-on. As the debate around vaccine safety intensifies, it is essential that all stakeholders—government bodies, pharmaceutical leaders, and healthcare institutions—participate in a unified, fact-based public conversation. Rebuilding and reinforcing public trust isn't just a policy goal. It's a shared responsibility.
NDTV
an hour ago
- NDTV
Anil Menon: NASA Astronaut To Fly To ISS On First Space Mission In 2026
Indian-origin astronaut Anil Menon has been assigned his first space mission by NASA. Mr Menon will serve as a flight engineer aboard the International Space Station (ISS) as part of Expedition 75. The mission is scheduled for launch in June 2026 aboard the Roscosmos Soyuz MS-29 spacecraft, alongside Russian cosmonauts Pyotr Dubrov and Anna Kikina. The crew will lift off from the Baikonur Cosmodrome in Kazakhstan and is expected to spend approximately eight months aboard the ISS. During the expedition, Anil Menon will support critical scientific research and technology demonstrations designed to advance long-duration human spaceflight and benefit life on Earth. Who Is Anil Menon? Anil Menon was born and raised in Minneapolis, Minnesota, to Indian and Ukrainian immigrant parents. He graduated from Saint Paul Academy and Summit School in 1995. He earned a bachelor's degree in neurobiology from Harvard University in 1999. At Harvard, he conducted research on Huntington's disease and later spent a year in India as a Rotary Ambassadorial Scholar supporting polio vaccination efforts. Anil Menon earned engineering and medical degrees from Stanford, followed by residencies in emergency and aerospace medicine, and a Master's in Public Health from University of Texas Medical Branch (UTMB) in 2012. During his training, Mr Menon joined the California Air National Guard, supported remote wilderness races and served as a first responder in major disasters including the Haiti and Nepal earthquakes. As part of Operation Enduring Freedom, he deployed to Afghanistan to provide emergency medical care. He was later transferred to the 173rd Fighter Wing, logging over 100 sorties in F-15s and transporting over 100 patients with the US Air Force's critical care air transport team. He joined NASA as a flight surgeon in 2014. In 2018, Anil Menon became SpaceX's first flight surgeon and helped launch the first crewed Dragon spacecraft during the Demo-2 mission. He was selected as a NASA astronaut in 2021 and reported for duty in January 2022. He completed two years of astronaut training and graduated with NASA's 23rd astronaut class in 2024. Anil Menon continues to practice emergency medicine at Memorial Hermann's Texas Medical Center and teaches at the University of Texas. He is married to Anna Menon, a SpaceX employee, and they have two children. Anil Menon has received numerous awards, including the US Air Force Commendation Medal, NASA and SpaceX team awards, and multiple honours for academic and medical excellence.
NDTV
an hour ago
- NDTV
Amid 'Korean Botox' Buzz On Social Media, Experts Tell NDTV What Not To Do
Innotox, colloquially known as "Korean Botox," is a type A botulinum toxin product, used for cosmetic procedures to reduce wrinkles, fine lines and other signs of ageing. Developed by the South Korean company Medytox, Innotox has gone viral on social media platforms like Instagram and TikTok because of its alleged convenience and has influenced millions worldwide. What is Innotox? "It is gaining traction due to its pre-diluted, ready-to-use liquid formulation," Dr Jisha Pillai, Dermatologist, Lilavati Hospital, Mumbai, told NDTV. Innotox temporarily blocks nerve signals to targeted facial muscles, preventing them from contracting and reducing the appearance of wrinkles. The treatment involves small injections into the target areas of the face. Shefali Jariwala's death Indian actor Shefali Jariwala's sudden death has stirred a debate on the use of such medications, especially in the absence of a professional. The anti-ageing and skin-lightening pills also come in vials and are injected directly into the skin, but users often do it unsupervised. Reports claimed that Jariwala consumed her anti-ageing drugs during fasting, which led to a drop in her blood pressure, causing her death. Unsupervised cosmetic procedures Although, Dr Pillai called it is "inappropriate" and "irresponsible" to link individual's death to cosmetic procedures without any confirmed medical evidence, she said the rise of K-beauty and injectable trends globally has inadvertently led to "increased misuse" of aesthetic treatments to promote "unrealistic expectations" without proper medical guidance. The usage of unregulated products and non-medical or unlicensed clinical injectors can pose serious health risks. "While botulinum toxin can be safe, it must only be administered by trained and board-certified professionals in clinical settings," Dr Pillai said. "Its misuse in non-clinical environments can lead to complications such as ptosis, asymmetry, muscle weakness, or long-standing nerve damage." What are the DOs and DONTs? Pre-Procedure Consultation: Discuss your medical history, allergies, medications, and treatment goals with a board-certified specialist. Medication Disclosure: Inform your doctor about all medications and supplements you're taking, especially blood thinners. Approved Vials: Ensure the use of FDA or CDSCO-approved vials stored under proper cold-chain conditions. Post-Injection Care: Avoid alcohol as it can increase bruising and swelling. Also, avoid heavy exercise and massaging or rubbing. Qualified Practitioner: Ensure the procedure is performed by a board-certified medical expert in a sterile environment. Verify Credentials: Check the practitioner's medical board certification and professional affiliations. Avoid Non-Medical Settings: Never get injections in salons or from unqualified individuals. Informed Consent: Ensure you provide proper consent and understand the risks and benefits of the procedure. "Not all trending skincare is safe skincare. Trends don't diagnose your medical/skin condition. Always choose evidence and scientific research-based care over viral trends/hype," Dr Pillai concluded. "Beauty is not just about how we look" Dr Sundeep Kochar, life coach and TEDx alumnus, told NDTV that true beauty is not just about how we look, but how we feel and what we radiate from within. In a time when outer appearance often takes centre stage, his message brings our focus back to what truly matters-inner peace, positive energy, and self-care. "While injections and beauty treatments may offer quick fixes, they can never replace the natural glow that comes from a calm mind, a kind heart, and a balanced lifestyle," Dr Kochar told NDTV. "When we practice meditation, eat nourishing food, stay in a peaceful environment, and treat others with compassion, we build a powerful and magnetic aura. This is the kind of beauty that lasts and leaves a deeper impact," Dr Kochar said. Dr Kochar emphasises a few essential DOs and DONTs to help cultivate lasting inner beauty. He advises practising daily meditation, mindful eating with fresh and sattvic food, maintaining a clutter-free environment, and engaging in uplifting conversations.
